114 related articles for article (PubMed ID: 9166163)
1. Immunohistochemistry of vascular changes in leuprolide acetate-treated leiomyomas.
Mesia AF; Gahr D; Wild M; Mittal K; Demopoulos RI
Am J Obstet Gynecol; 1997 May; 176(5):1026-9. PubMed ID: 9166163
[TBL] [Abstract][Full Text] [Related]
2. Leuprolide acetate depot for the treatment of uterine leiomyomas. Changes in bone density, uterine volume and uterine vascular resistive index.
Rivlin ME; Patel RB; Hess LW; Hess DB; Meeks GR
J Reprod Med; 1994 Sep; 39(9):663-6. PubMed ID: 7807474
[TBL] [Abstract][Full Text] [Related]
3. Clinical response, vascular change, and angiogenesis in gonadotropin-releasing hormone analogue-treated women with uterine myomas.
Di Lieto A; De Falco M; Pollio F; Mansueto G; Salvatore G; Somma P; Ciociola F; De Rosa G; Staibano S
J Soc Gynecol Investig; 2005 Feb; 12(2):123-8. PubMed ID: 15695108
[TBL] [Abstract][Full Text] [Related]
4. Histopathologic findings in 107 uterine leiomyomas treated with leuprolide acetate compared with 126 controls.
Sreenan JJ; Prayson RA; Biscotti CV; Thornton MH; Easley KA; Hart WR
Am J Surg Pathol; 1996 Apr; 20(4):427-32. PubMed ID: 8604809
[TBL] [Abstract][Full Text] [Related]
5. Suppression of cell proliferation and induction of apoptosis in uterine leiomyoma by gonadotropin-releasing hormone agonist (leuprolide acetate).
Mizutani T; Sugihara A; Nakamuro K; Terada N
J Clin Endocrinol Metab; 1998 Apr; 83(4):1253-5. PubMed ID: 9543151
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical study of a case of uterine leiomyoma showing massive lymphoid infiltration and localized vasculitis after LH-RH derivant treatment.
Ohmori T; Wakamoto R; Lu LM; Okada K; Nose M
Histopathology; 2002 Sep; 41(3):276-7. PubMed ID: 12207795
[No Abstract] [Full Text] [Related]
7. Massive ascites after leuprolide acetate administration for the treatment of leiomyomata uteri.
Lee MJ; Kazer RR
Fertil Steril; 1992 Aug; 58(2):416-8. PubMed ID: 1633912
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of leuprolide acetate treatment on histopathology of uterine myomata.
Gutmann JN; Thornton KL; Diamond MP; Carcangiu ML
Fertil Steril; 1994 Apr; 61(4):622-6. PubMed ID: 8150102
[TBL] [Abstract][Full Text] [Related]
9. The hemodynamic effect of GnRH agonist therapy on uterine leiomyoma vascularity: a prospective study using transvaginal color Doppler sonography.
Aleem FA; Predanic M
Gynecol Endocrinol; 1995 Sep; 9(3):253-8. PubMed ID: 8540296
[TBL] [Abstract][Full Text] [Related]
10. Histology of leiomyomata in patients treated with leuprolide acetate.
Demopoulos RI; Jones KY; Mittal KR; Vamvakas EC
Int J Gynecol Pathol; 1997 Apr; 16(2):131-7. PubMed ID: 9100066
[TBL] [Abstract][Full Text] [Related]
11. Long-term effectiveness and safety of GnRH agonist plus raloxifene administration in women with uterine leiomyomas.
Palomba S; Orio F; Russo T; Falbo A; Cascella T; Doldo P; Nappi C; Lombardi G; Mastrantonio P; Zullo F
Hum Reprod; 2004 Jun; 19(6):1308-14. PubMed ID: 15117890
[TBL] [Abstract][Full Text] [Related]
12. Differences in fibroid vascularity after three months of pre-treatment with leuprolide acetate or ulipristal acetate: A pilot study.
Frijlingh M; De Milliano I; Hehenkamp WJK; Huirne JAF
Eur J Obstet Gynecol Reprod Biol; 2020 Feb; 245():186-192. PubMed ID: 31679806
[TBL] [Abstract][Full Text] [Related]
13. Relationship between platelet-derived growth factor expression in leiomyomas and uterine volume changes after gonadotropin-releasing hormone agonist treatment.
Di Lieto A; De Rosa G; De Falco M; Iannotti F; Staibano S; Pollio F; Scaramellino M; Salvatore G
Hum Pathol; 2002 Feb; 33(2):220-4. PubMed ID: 11957148
[TBL] [Abstract][Full Text] [Related]
14. Effects of leuprolide acetate on treatment of leiomyomata--clues to mechanisms of action.
Demopoulos RI; Mesia AF
Adv Anat Pathol; 1998 Mar; 5(2):129-36. PubMed ID: 9868519
[No Abstract] [Full Text] [Related]
15. Effects of gonadotropin-releasing hormone agonists on uterine leiomyomas.
Cramer SF
Arch Pathol Lab Med; 1998 Dec; 122(12):1045-6. PubMed ID: 9870847
[No Abstract] [Full Text] [Related]
16. Short term treatment with leuprolide acetate is a successful adjunct to surgical therapy of leiomyomas of the uterus.
Coddington CC; Brzyski R; Hansen KA; Corley DR; McIntyre-Seltman K; Jones HW
Surg Gynecol Obstet; 1992 Jul; 175(1):57-63. PubMed ID: 1621201
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical detection of insulin-like growth factor type I receptor and uterine volume changes in gonadotropin-releasing hormone analog-treated uterine leiomyomas.
Di Lieto A; Iannotti F; De Falco M; Staibano S; Pollio F; Ciociola F; De Rosa G
Am J Obstet Gynecol; 2003 Mar; 188(3):702-6. PubMed ID: 12634644
[TBL] [Abstract][Full Text] [Related]
18. Aborted leiomyosarcoma after treatment with leuprolide acetate.
Mesia AF; Williams FS; Yan Z; Mittal K
Obstet Gynecol; 1998 Oct; 92(4 Pt 2):664-6. PubMed ID: 9764655
[TBL] [Abstract][Full Text] [Related]
19. [Advanced endometriosis treatment with leuprolide acetate].
Valdés P; Sierralta P
Rev Chil Obstet Ginecol; 1993; 58(5):405-10. PubMed ID: 7991863
[TBL] [Abstract][Full Text] [Related]
20. Leuprolide acetate treatment and myoma arterial size.
Rutgers JL; Spong CY; Sinow R; Heiner J
Obstet Gynecol; 1995 Sep; 86(3):386-8. PubMed ID: 7651647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
